Hyperhomocysteinemia is an active player implicated in the pathophysiology of mild cognitive impairment, a prodromal condition strongly predictive of subsequent AD development [80], and AD sequence by provoking Aβ and tau pathologies, along with synaptic dysfunction, neuroinflammatory process and memory decline. This evidence concerns the gene MAPT and Alzheimer disease.